Epocrates and iatroX can be useful at different points in a medicines enquiry. A product lookup, an interaction check, identifying an unfamiliar tablet and understanding a clinical recommendation are not the same task. Choose the tool around the information you need, rather than assuming one app must replace the other.
This updated comparison is published by iatroX and includes its own services. Public information was checked on 20 September 2026. The examples are fictional learning tasks, not authenticated product tests or patient-specific recommendations.
At a glance: what Epocrates currently describes
The developer's current US App Store listing describes drug monographs, interaction checking, pill identification, laboratory references and broader disease-related information. It presents a free download with paid in-app purchases. That is not evidence that every feature is free, nor a reason to describe Epocrates as useful only for identifying tablets.
The listing's US clinical orientation matters when examining terminology, product availability and prescribing context. It does not, by itself, prove that the app can only be downloaded or read in the United States. Geography of content and eligibility for access are separate questions.
Ask-iatroX's published role is linked-source clinical clarification, with a UK-oriented reference collection and a wider medical-learning platform. It is not presented here as a dedicated pill-identification service or a validated substitute for specialist interaction checking. iatroX methodology
The blue oval tablet is an identification problem
The earlier comparison used the example of an unfamiliar blue oval pill. That remains a useful way to distinguish tasks, but appearance alone should not be turned into an identification conclusion in an article or a general AI conversation.
In an original teaching scenario, a patient brings an unlabelled tablet and an incomplete medicines list. The learner should establish what reliable information is available, including packaging, dispensing information and any product markings, and use the appropriate professional identification process. A colour description is not enough to authorise administration.
Epocrates advertises a pill-identification function using identifying characteristics. That is a relevant feature to inspect, not a guarantee that every unknown tablet can be resolved. The result still needs appropriate verification and clinical context. Epocrates product listing
An iatroX learning question could instead ask why product identity must be established before interpreting a monograph. That helps the learner understand the process without pretending that the reference assistant has identified the actual tablet.
A monograph answers a different question
Once the product has been established, the enquiry may concern a warning, contraindication or unfamiliar pharmacology term. A drug monograph is the natural place to inspect the relevant product information.
A useful reading process distinguishes what the source states from what the reader infers. Does the entry refer to the actual formulation? Is the population the same? Is the statement about a class, an individual medicine or a particular product? These distinctions matter before moving from information to action.
For a UK product-specific question, the exact SmPC available through emc may also be relevant. This is not a claim that a US reference is generally inferior. It is recognition that product information and local clinical context can differ. About emc
If the obstacle is terminology, an explanatory tool can help. For example, the learner may need to distinguish a mechanism from a precaution. The answer should make the distinction clearer while directing the reader back to the appropriate source for the actual clinical decision.
What about interactions and formulary information?
The original comparison discussed interaction checking and US formulary context. Retain those as questions to investigate, but avoid unsupported claims that a checker is the most widely used or that a particular entitlement is universally included.
A sensible account audit records which interaction functions are available, the information entered and how supporting details can be inspected. For formulary or coverage information, establish the relevant health plan or local system, update date and access tier. Do not treat a generic product overview as confirmation of a person's current coverage.
This review verified the current developer listing, not a complete authenticated tier-by-tier account. Therefore it does not assign every function to a specific free or paid plan or quote a single supposedly universal subscription price. Check the purchase screen and terms that apply to the intended account.
A COPD question is a clinical-context problem
The earlier page also used COPD and GOLD guidance as a contrast. That example should not imply that Epocrates lacks all disease or guideline content: its current listing describes broader clinical-reference functions.
Instead, use a fictional learner who understands a medicine monograph but cannot explain why a guideline places different patients on different pathways. The learning question concerns the information used to choose a pathway, the guidance edition and the intended setting. It is not answered simply by reading an individual medicine's properties.
A focused Ask-iatroX question can request an explanation of the relevant distinctions with linked sources. The reader should inspect the guideline itself before applying the explanation. This article does not supply a COPD regimen or claim that either product produced a particular answer.
The task is to connect the clinical question to the medicine information without treating either as sufficient alone. Knowing what a medicine does and establishing whether a particular patient should receive it require overlapping but different information.
From a lookup to a learning objective
After the enquiry, identify the concept that remained difficult. "Read about COPD" is broad. "Explain why the guideline question cannot be answered from a product monograph alone" is specific and assessable.
iatroX's September 2026 educational offering includes question-specific Socratic tutoring, a study planner, simulations and reviewed CPD records alongside its banks. These features can support a relevant learning goal, but do not turn every drug lookup into a completed educational activity automatically. iatroX Tutor
An original practice task might ask the learner to choose which source would resolve three different uncertainties: an unidentified product, an unfamiliar pharmacology term and a locally relevant management question. Their explanation is more informative than whether they remember a brand name.
Access and value by scenario
For someone repeatedly checking medicines, identifying products or using Epocrates' documented clinical utilities, evaluate those functions in the actual account. For someone needing a focused UK-source explanation or structured learning after a knowledge gap, include iatroX in the assessment.
As published on 20 September 2026, Ask-iatroX and available free question access remain free. The UK all-access learning subscription is £99 paid upfront annually or £29 monthly and includes paid banks, Tutor, planner, simulations and CPD. The annual price is equivalent to £8.25 monthly when billed annually.
A specialist reference may remain necessary even when a broad learning subscription is good value. The decision should follow the task, not a claim that one affordable application reproduces every clinical utility.
Frequently asked questions
Is all of Epocrates free?
The reviewed listing describes a free download with paid purchases, not unrestricted access to every function. Check the exact account and current purchase terms.
Does iatroX identify an unknown pill?
No dedicated pill-identification capability is claimed in this comparison. Use an appropriate verified identification process rather than rely on a general text description.
Can Epocrates and iatroX be used together?
Yes, where they serve different tasks such as a drug lookup and a subsequent learning question. There is no need to purchase overlapping functions without an identified benefit.